Table 6.
Associations between apolipoprotein B and β2-glycoprotein-I (GPI) autoantibodies and age in systemic lupus erythematosus (SLE) patients and controls
| SLE patients (n = 434) | P | Controls (n = 322) | P | |
|---|---|---|---|---|
| Apolipoprotein B antibodies | ||||
| p45 IgM | −0·19 | 0·001 | −0·24 | 0·001 |
| MDA-p45 IgM | −0·22 | 0·001 | −0·24 | 0·001 |
| p45 IgG | −0·17 | 0·001 | −0·12 | 0·04 |
| MDA-p45 IgG | −0·16 | 0·001 | −0·07 | n.s. |
| p210 IgM | −0·26 | 0·001 | −0·26 | 0·001 |
| MDA-p210 IgM | −0·19 | 0·001 | −0·21 | 0·001 |
| p210 IgG | −0·29 | 0·001 | −0·28 | 0·001 |
| MDA-p210 IgG | −0·30 | 0·001 | −0·27 | 0·001 |
| Apolipoprotein H antibodies | ||||
| β2GPI IgM | 0·07 | n.s. | 0·12 | 0·04 |
| β2GPI IgG | 0·01 | n.s. | 0·09 | n.s. |
Ig = immunoglobulin; MDA = malondialdehyde; n.s. = not significant.